Drug Search Results
More Filters [+]

Mephentermine

Alternative Names: mephentermine, wyamine sulfate
Latest Update: 2023-10-06
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: ADRB Agonist,ADRA1A Agonist,ADRA1B Agonist,ADRA1D Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Approved

Approved Countries: Canada | India | Portugal | Taiwan

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Mephentermine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title